The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities

Introduction

‘The Specialty Pharma Market Outlook’ evaluates the current specialty pharma models, financial performance, core strategies and future outlook of companies in the field. This report also examines key specialty markets, providing valuable insights into market dynamics while profiling trends that influence market opportunities in therapeutic indications.

Scope of this research

• Assessment of the critical factors that define technological specialization strategies among specialty pharma companies.
• Examination of the future challenges faced by companies that specialize in drug delivery or reformulation.
• Analysis of the market trends within the major specialty therapy areas.
• Details of the types of company best positioned to succeed in the specialty pharmaceutical markets.
• Breakdown of the key emerging strategies for pharmaceutical companies to establish a presence and operate within the specialty market in the future.

Research and analysis highlights

Despite high genericization, treatments for cardiovascular disorders continue to remain popular among specialty pharmaceutical companies. This indication generated revenues of $4,600m in 2005, with anti-hypertensives accounting for $1.2 billion or 26.7% of total sales.

In 2005, CNS disorders held the highest share of the specialty pharmaceutical market of any therapeutic area, estimated at 22.1% or $11,500m.

Increased competition for the strongest licensing opportunities is forecast to affect companies specializing in sales and marketing, with scale remaining a key constituent of competitive advantage.

Key reasons to purchase this research

• Gain a detailed overview of the specialty pharmaceutical market, including segmentation by company type and analysis of deal flow, licensing and M&A.
• Identify therapeutic opportunities and threats in the therapy areas of cardiovascular, CNS, ophthalmology, dermatology, women’s health and urology.
• Analyze the growth strategies of the leading players, using the product portfolio, SWOT and financial performance analysis contained in this report.
• Understand the current market dynamics of pharma companies focusing on niche indications.
• Implement the most attractive growth models and company strategies for future success.